Viapath Implementing diagnostics.ai to Automate and Digitise Their Molecular Diagnostics
LONDON, Jan. 12, 2018 /PRNewswire/ -- Viapath is one of the largest pathology service providers in the UK, serving their founding NHS Trusts, other NHS and private hospitals, and the GP community at large. Viapath is committed to the use of cutting-edge technology to ensure that diagnostics are as accurate and efficient as possible.
Following successful trials and commercial evaluations, Viapath has agreed implementation terms for diagnostics.ai's unique artificial intelligence (AI) technology. This technology automates the analysis and reporting of results, with built-in quality control, ensuring accuracy and standardisation. The innovative system removes manual steps, delivering a digitised and paperless system (tying into the NHS Five Year Forward View- Paperless 2020), as well as enabling faster turnaround, reduced risk and improved laboratory capacity.
The first laboratory implementation will be Viapath's flagship South London Specialist Virology Centre at King's College Hospital. The first systems to be automated will be the high-volume real-time PCR testing, used for a wide range of sample types and tests including respiratory, STD and gastrointestinal through the use of diagnostics.ai's cloud-based service, pcr.ai. The implementation will begin in February 2018, demonstrating Viapath's continued commitment to setting the standard for the future of pathology.
Dr Melvyn Smith, Principal Clinical Scientist, Infection Sciences and King's College Hospital's South London Specialist Virology Centre said; "Diagnostic services across the NHS are experiencing a significant growth in demand for both the volume and variety of tests performed. At Viapath we aim to maintain the quality of care and results through continued improvement of services. diagnostics.ai's innovative technology helps us to deal with laboratory pressures in a safe and efficient manner."
Dr M Sudhanva, Consultant Virologist and Clinical Director of Pathology for Viapath's laboratories at King's College Hospital said; "We are delighted to continue our work with the diagnostics.ai team. As a leading diagnostic provider Viapath strive to continuously integrate new technologies for the benefit of our patients, hospitals and staff. We have been impressed with diagnostics.ai for some time, and believe that integrating their technology will improve our efficiency and reduce the costs of maintaining stringent regulatory standards, including ISO15189."
Aron Cohen, CEO of diagnostics.ai echoed these comments, saying; "We are proud to be supplying the highly expert and professional team at Viapath. We believe strongly in the vision of automating medicine and diagnostics, and are delighted that Viapath has selected to work with us for automation and digitisation of their workflow. Our systems integrate seamlessly with existing laboratory equipment to deliver significant hands-on and cost savings, and we look forward to actualising these with Viapath."
Contact us
Debbie Bowman
Internal Communications Manager
Viapath
Francis House,
9 King's Head Yard,
London,
SE1 1NA
0207 188 7188 ext.55397
[email protected]
Aron Cohen
CEO
diagnostics.ai
59a Brent Street
London
NW4 2EA
01234 480 240
[email protected]
Note to Editors
About Viapath: Viapath is a unique partnership of clinical, scientific and operational expertise, with a mission to transform pathology services in the UK. The organisation is built on scientific expertise, providing a service that helps clinicians create better outcomes for patients every day. Viapath's full-service, customer-focused offer is strongly rooted in the patient pathway, serving founding NHS Trusts, other NHS and private hospitals, and the GP community at large. The company is continually focused on innovation, finding new and better ways to manage the logistics of high-volume pathology testing as well as specialist reference testing, always striving to improve capabilities to better meet the needs of medical professionals and patients.
About diagnostics.ai: diagnostics.ai's multi-patented AI based technology is being used in the UK, USA and India to improve laboratory efficiency and standardisation. The company's products and services automate interpretation of diagnostic machine outputs. This reduces dependency on manual steps and experts - lowering costs and improving quality and accuracy. The company is in a high-growth phase, as global demand for healthcare automation continues to increase.
SOURCE Viapath; diagnostics.ai
Share this article